Abstracts Archive - Page 1736 of 2425 - ACR Meeting Abstracts

Abstract Number: 698 • 2015 ACR/ARHP Annual Meeting
Is It Possible to Identify Psoriasis Patients Who Will Develop Axial Disease? Real Life Data from Psart (Psoriatic Arthritis Registry of Turkey)
Sibel Z. Aydin¹, Ozun BayndÄ±r¹, Barış Yılmazer¹, Kenan Aksu¹, Ediz Dalkilic², Mustafa Ferhat Oksuz¹, E.Figen Tarhan¹, Meryem Can¹, Orhan Kucuksahin¹, Gezmis Kimyon¹, Lutfi Akyol¹, Ahmet Mesut Onat¹, Bunyamin Kisacik¹, Abdulsamet Erden¹, Ahmet Omma¹, Duygu Ersozlu Bakirli¹, Cem Ozisler¹, Emel Gonullu¹, Seval Pehlevan¹, Dilek Solmaz¹, Muhammet Cinar¹, Gozde Cetin¹, Abdurrahman Tufan¹, Muge Aydin Tufan¹, Levent Kilic¹, Sukran Erten¹, Timucin Kasifoglu¹, Senol Kobak¹, Soner Senel¹, Servet Akar¹, Metin Ozgen¹, Esen Kasapoglu-Gunal¹, Veli Yazisiz¹, Sedat Yılmaz¹, Salim Donmez¹, Ä°smail Dogan¹, Hamide Kart Koseoglu¹, Funda Erbasan¹, Fatih Yildiz¹, Cemal Bes¹, Ayse Balkarli¹, Ali Sahin¹, Rıdvan Mercan¹, Fatoş Arslan¹, Atalay Dogru¹, Salih Pay¹, Sule Yavuz¹, Necati Cakir¹, Yasemin Kabasakal¹ and Umut Kalyoncu¹, ¹PsART study group, Ankara, Turkey, ²Department of Rhematology, Uludag University Faculty of Medicine, Bursa, Turkey
Is it possible to identify psoriasis patients who will develop axial disease? Real life data from PsART (Psoriatic Arthritis Registry of Turkey)S. Z. Aydýn, Ö.…
Abstract Number: 699 • 2015 ACR/ARHP Annual Meeting
Improving Ankylosing Spondylitis Specific Outcomes at 6 Months Utilising a Novel Self-Management Education Program
Charles Inderjeeth^1,2,3,4, Jean McQuade⁵, Warren Raymond⁶, Clara Connor⁷, Jack Edelman⁸, Nicola Cook⁹ and Kathy Briffa¹⁰, ¹Rehabiltation and Aged care and Rheumatology, Sir Charles Gairdner Hospital and University of Western Australia, Nedlands, Australia, ²North Metropolitan Health Service, University of Western Australia, Perth, WA, Australia, ³Subiaco Rheumatology Clinic, Subiaco, Australia, ⁴Linear Clinical Research Ltd, Perth, Australia, ⁵Arthritis WA, Wembley, Australia, ⁶Rheumatology and Geriatric Medicine, Sir Charles Gairdner Hospital and University of Western Australia, Nedlands, Australia, ⁷Arthritis and Osteoporosis WA, Perth, Australia, ⁸Rheumatology, Sir Charles Gairdner Hospital, Perth, Australia, ⁹Royal Perth Hospital, Perth, Australia, ¹⁰School of Physiotherapy and Exercise Science, Curtin University, Perth, Australia
Background/Purpose : Disease specific self-management interventions are rare. After a needs assessment, focus group discussions, and Plan, Do, Study, Act (PDSA) model we developed and…
Abstract Number: 700 • 2015 ACR/ARHP Annual Meeting
Problems of Untranslatability: Example of Turkish Version of Basdai
Pamir Atagunduz¹, Elmar Mammadov², Ina Dervishi², Metin Beyatlı², Kubra Nur Salcı³, Nafisa Auwal Abdulhamid⁴, Gulsen Ozen⁵, Ali Ugur Unal¹, Zeynep Erturk¹, Nevsun Inanc⁵ and Haner Direskeneli⁵, ¹Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, ²None, Marmara University School of Medicine, Istanbul, Turkey, ³Marmara University School of Medicine, istanbul, Turkey, ⁴Marmara University School of Medicine, Istanbul, Turkey, ⁵Department of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey
Background/Purpose: Translators of self-report forms commonly encounter problems related to untranslatability, a term used to describe words that cannot be meaningfully translated from one language…
Abstract Number: 701 • 2015 ACR/ARHP Annual Meeting
Is Skin Disease More Important to Women or Men in the Assessment of Disease Activity in Psoriatic Arthritis?
Maqbool Sheriff¹, Michel Zummer², J Antonio Avina-Zubieta³, Proton Rahman⁴, Wojciech Olszynski⁵, Michael Starr⁶, Philip Baer⁷, Emmanouil Rampakakis⁸, Eliofotisti Psaradellis⁹, Cathy Tkaczyk¹⁰, Brendan Osborne¹⁰, Karina Maslova¹¹, Francois Nantel¹² and Allen J Lehman¹¹, ¹Nanaimo Regional General Hospital, Nanaimo, BC, Canada, ²Rheumatology, Hôpital Maisonneuve-Rosemont and University of Montreal, Montreal, QC, Canada, ³Medicine, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁴Rheumatology, St. Clare's Mercy Hospital, St. John's, NF, Canada, ⁵University of Saskatchewan, Saskatoon, SK, Canada, ⁶Rheumatology, McGill University, Montreal, QC, Canada, ⁷Section on Rheumatology, Ontario Medical Association/Journal of the Canadian Rheumatology Association, Toronto, ON, Canada, ⁸JSS Medical Research, St-Laurent, QC, Canada, ⁹JSS Medical Research, Montreal, QC, Canada, ¹⁰Medical Affairs, Janssen Inc., Toronto, ON, Canada, ¹¹Janssen Inc., Toronto, ON, Canada, ¹²19 Green belt Dr, Janssen Inc., Toronto, ON, Canada
Background/Purpose: Patient global assessment of disease activity (PtGA) is a standard outcome measure used both in randomized controlled trials and in clinical practice to ascertain…
Abstract Number: 702 • 2015 ACR/ARHP Annual Meeting
Is Skin Disease More Important to Patients or Physicians in the Assessment of Disease Activity in Psoriatic Arthritis?
Dalton Sholter¹, Proton Rahman², J Antonio Avina-Zubieta³, John Kelsall⁴, Regan Arendse⁵, Majed M. Khraishi⁶, S Shaikh⁷, William G. Bensen⁸, Emmanouil Rampakakis⁹, John S. Sampalis¹⁰, Francois Nantel¹¹, May Shawi¹², Susan Otawa¹³, Cathy Tkaczyk¹³ and Allen J Lehman¹², ¹Rheumatology Associates, Edmonton, AB, Canada, ²Rheumatology, St. Clare's Mercy Hospital, St. John's, NF, Canada, ³Medicine, University of British Columbia, Department of Medicine, Division of Rheumatology, Vancouver, BC, Canada, ⁴Mary Pack Arthritis Centre, Vancouver, Vancouver, BC, Canada, ⁵University of Saskatchewan, Saskatoon, SK, Canada, ⁶Nexus Clinical Research, St Johns, NF, Canada, ⁷Niagara Peninsula Arthritis Centre, Hamilton, ON, Canada, ⁸St Joseph's Healthcare Hamilton, Hamilton, ON, Canada, ⁹JSS Medical Research, St-Laurent, QC, Canada, ¹⁰McGill University, Montreal, QC, Canada, ¹¹19 Green belt Dr, Janssen Inc., Toronto, ON, Canada, ¹²Janssen Inc., Toronto, ON, Canada, ¹³Medical Affairs, Janssen Inc., Toronto, ON, Canada
Background/Purpose: Patient (PtGA) and physician (MDGA) global assessment of disease activity are standard outcome measures used in clinical practice and research to ascertain patient and…
Abstract Number: 703 • 2015 ACR/ARHP Annual Meeting
Isotretinoin-Induced Spondilartropathy-Related Symptoms: A Prospective Study
Bunyamin Kisacik¹, Nuriye Kayiran², Orhan Zengin¹, Ali Kalem³, Gezmis Kimyon⁴, Emine Ozkul Kilinc³, Yavuz Pehlivan⁵, Necmettin Kirtak⁶ and Ahmet Mesut Onat⁴, ¹Ä°nternal Medicine Division of Rheumatology, Gaziantep University, Faculty of Medicine, Gaziantep, Turkey, ²physician, Gaziantep, Turkey, ³Physician, Gaziantep, Turkey, ⁴PsART study group, Ankara, Turkey, ⁵Department of Rheumatology, Uludag University Faculty of Medicine, Bursa, Turkey, ⁶Prof., Gaziantep, Turkey
Background/Purpose: Acne vulgaris is a chronic inflammatory disease of accumulation of the pilosebaceous unit in the skin and has a multifactorial aetiology. Isotretinoin is a…
Abstract Number: 704 • 2015 ACR/ARHP Annual Meeting
Is Axial Involvement Underestimated in Patients with Psoriatic Arthritis? Data from the Bepas Cohort
Kurt de Vlam¹, Rik Lories², Serge Steinfeld³, Filip van Den Bosch⁴, Adrien Nzeusseu Toukap⁵, Michel G. Malaise⁶, Veerle Taelman⁷, Filip van Bruwaene⁸, Marc Vanden Bergh⁹, Rik Joos¹⁰, Jan Lenaerts¹¹, Piet Geusens¹², Silvano Dalli'Armelina¹³, Isabelle Peene¹⁴, Griet De Brabanter¹⁵, Marthe van den Berghe¹⁶, Jiangang Qu¹⁷, Martin Maertens¹⁸ and Hermine Leroi¹⁹, ¹Katholieke Universiteit Leuven, Leuven, Belgium, ²university hospitals leuven, Leuven, Belgium, ³clinique saint jean, bruxelles, Belgium, ⁴Rheumatology, Ghent University Hospital, VIB, Ghent, Belgium, ⁵Department of Rheumatology, Cliniques Universitaires St Luc, Brussels, Belgium, ⁶Department of Rheumatology- GIGA Research - Arthropôle - University of Liège - CHU Liège, Liège, Belgium, ⁷Heilig Hart ziekenhuis, Leuven, Belgium, ⁸H.H. Ziekenhuis, Roeselare, Belgium, ⁹Grand Hôpital de Charleroi Saint Joseph, Charleroi, Belgium, ¹⁰ZNA Jan Palfijn, Antwerpen, Belgium, ¹¹Reuma Instituut, Hasselt, Belgium, ¹²reumaclinic, Genk, Belgium, ¹³Notre Dame de Grace, Gosselies, Belgium, ¹⁴Rheumatology, AZ sint Jan Brugge, 8000 Brugge, Belgium, ¹⁵AZ St Lucas, Assebroek, Belgium, ¹⁶ASZ, Aalst, Belgium, ¹⁷Iris Sud, Bruxelles, Belgium, ¹⁸AZ Damiaan, Oostende, Belgium, ¹⁹MSD Belgium, Bruxelles, Belgium
Background/Purpose: Psoriatic arthritis (PsA) is a common form of chronic arthritis strongly associated with the skin disease psoriasis. Although PsA has been included in the…
Abstract Number: 705 • 2015 ACR/ARHP Annual Meeting
Sex Differences in Psoriatic Arthritis: Evaluation of a Real-Life Cohort of 2,118 Italian Patients Treated with Methotrexate
Carlo Selmi^1,2, Elena Generali³, Greta Carrara⁴, Carlo Alberto Scirè⁴ and RECORD Study Group of the Italian Society for Rheumatology, ¹BIOMETRA Department, University of Milan, Milan, Italy, ²Internal Medicine- Unit of Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center, Rozzano, Italy, ³Internal Medicine- Unit of Rheumatology and Clinical Immunology, Humanitas Clinical and Research Center, Rozzano (MI), Italy, ⁴Epidemiology Unit – Italian Society for Rheumatology (SIR), Milano, Italy
Background/Purpose: The influence of sex in psoriatic arthritis (PsA) features and treatment outcomes has not been fully elucidated. We investigated the differences between sexes in…
Abstract Number: 706 • 2015 ACR/ARHP Annual Meeting
Undifferentiated Spondylarthritis May More Frequent in Japanese
Hitoshi Goto¹, Noriyuki Hayashi¹, Shinsuke Yamada² and Masaaki Inaba³, ¹Rheumatology, Osaka City University Graduate School of Medicine, Osaka, Japan, ²Rheumatology, Osaka City University Graduate School of Midicine, Osaka, Japan, ³Osaka City University Graduate School of Medicine, Osaka, Japan
Background/Purpose: Because of low frequency of HLA-B27 (lower than 1%), the prevalence of the spondarthritis (SpA) is thought to be much lower than rheumatoid arthritis…
Abstract Number: 707 • 2015 ACR/ARHP Annual Meeting
Change of Enthesial Involvement Under Treatment Was Independent from the Therapeutic Strategy in Patients with Axial Spondyloarthritis within the Scqm Cohort
Ruediger Mueller¹, Toni Kaegi², Nicole Graf³, Johannes von Kempis⁴ and J.J. Luime⁵, ¹Rheumatology, MD, St. Gallen, Switzerland, ²Kantonsspital St. Gallen, St. Gallen, Switzerland, ³graf biostatistics, Winterthur, Switzerland, ⁴Rheumatology, Kantonsspital St. Gallen, St. Gallen, Switzerland, ⁵Department of Rheumatology, Erasmus Medical Centre, Rotterdam, Netherlands
Background/Purpose: Enthesitis is one of the potential extra-axial manifestations found in patients with spondyloarthritis (SpA). Enthesitis can be quantified using the MASES (Maastrich Ankylosing Spondylitis…
Abstract Number: 708 • 2015 ACR/ARHP Annual Meeting
Development of an Activity Disease Score in Patients with Uveitis
Esperanza Pato Cour¹, Maria Auxiliadora Martin², Santiago MuÑoz Fernandez³, Adela Castello⁴, Fernando Sanchez-Alonso⁵, David Diaz-Valle⁶, Rosalía Mendez⁷ and Uveitis MeVa Group, ¹Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, ²Research Unit of Spanish Society of Rheumatology,, Madrid, Spain, ³Rheumatology, Hospital Infanta Sofía, Madrid, Spain, ⁴Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain, Madrid, Spain, ⁵Unidad de Investigación, Spanish Society of Rheumatology, Madrid, Spain, ⁶Hospital Clínico San Carlos de Madrid, Madrid, Spain, ⁷Ophthalmology, Hospital Clínico San Carlos, Madrid, Spain
Background/Purpose: Uveitis is commonly defined as inflammation of the uvea, the vascular middle layer of the eye. Standardized and validated outcome measures are lacking in…
Abstract Number: 709 • 2015 ACR/ARHP Annual Meeting
Progression of Patients with Non-Radiographic Axial Spondyloarthritis to Ankylosing Spondylitis: A Population-Based Cohort Study
Runsheng Wang¹, Sherine Gabriel² and Michael M. Ward¹, ¹NIH/NIAMS, Bethesda, MD, ²Division of Rheumatology; Department of Health Sciences Research, Mayo Clinic, Rochester, MN
Background/Purpose: The long-term outcome of patients with non-radiographic axial spondyloarthritis (nr-axSpA) is unclear, particularly whether few or most progress to ankylosing spondylitis (AS). Our objective…
Abstract Number: 710 • 2015 ACR/ARHP Annual Meeting
Baseline Characteristics of Early, Delayed, and Non-Responders in a Non-Radiographic Axial Spondyloarthritis Study
Walter Maksymowych¹, Jack F Bukowski², Lisa Marshall³, Annette Szumski⁴ and Heather Jones³, ¹Department of Medicine, University of Alberta, Edmonton, AB, Canada, ²Clinical Affairs, Pfizer, Collegeville, PA, ³Inflammation Global Medical Affairs, Pfizer, Collegeville, PA, ⁴Department of Biostatistics, Pfizer, Collegeville, PA
Background/Purpose: Most clinical trials evaluating anti-TNF agents for treating non-radiographic axial SpA (nr-axSpA) place the primary endpoint at 12 wks, and most formularies require assessment…
Abstract Number: 711 • 2015 ACR/ARHP Annual Meeting
Gender Specific Differences in Ankylosing Spondylitis at Treatment Initiation in Patients Treated with Infliximab or Golimumab
Michael Starr¹, Michel Zummer², Denis Choquette³, Boulos Haraoui⁴, Proton Rahman⁵, Maqbool Sheriff⁶, Niall Jones⁷, Emmanouil Rampakakis⁸, Eliofotisti Psaradellis⁹, Brendan Osborne¹⁰, Allen J Lehman^10,11, Karina Maslova¹¹, Francois Nantel^12,13 and Cathy Tkaczyk¹⁰, ¹Rheumatology, McGill University, Montreal, QC, Canada, ²Rheumatology, Hôpital Maisonneuve-Rosemont and University of Montreal, Montreal, QC, Canada, ³Rheumatology Department, Institut de Rhumatologie de Montréal and University of Montreal, Montreal, QC, Canada, ⁴Institut de Rhumatologie de Montréal and University of Montreal, Montreal, QC, Canada, ⁵Medicine, Memorial University, St John's, NF, Canada, ⁶Nanaimo Regional General Hospital, Nanaimo, BC, Canada, ⁷Division of Rheumatology, University of Alberta, Edmonton, AB, Canada, ⁸JSS Medical Research, St-Laurent, QC, Canada, ⁹JSS Medical Research, Montreal, QC, Canada, ¹⁰Medical Affairs, Janssen Inc., Toronto, ON, Canada, ¹¹Janssen Inc., Toronto, ON, Canada, ¹²Schering Plough Canada Inc., Janssen Inc., Kirkland, QC, QC, Canada, ¹³19 Green belt Dr, Janssen Inc., Toronto, ON, Canada
Background/Purpose: The prevalence of ankylosing spondylitis (AS) is 2-3 times higher in men compared to women. Recent studies have suggested that clinical differences exist between…
Abstract Number: 712 • 2015 ACR/ARHP Annual Meeting
Factors Associated with Anti-TNF Treatment in a Longitudinally Followed Ankylosing Spondylitis (AS) Cohort
Mary Gibson¹, MinJae Lee², Michael M. Ward³, Lianne S. Gensler⁴, Matthew A. Brown⁵, Shervin Assassi⁶, Colton Pence¹, Laura A. Diekman⁷, Mohammad H. Rahbar⁸, Michael H. Weisman⁹ and John D. Reveille¹, ¹Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, ²Biostatistics/Epidemiology/Research Design (BERD) Core | Center for Clinical and Translational Sciences, University of Texas Health Science Center at Houston, Houston, TX, ³NIH/NIAMS, Bethesda, MD, ⁴Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ⁵The University of Queensland Diamantina Institute, Brisbane, Australia, ⁶Rheumatology, University of Texas Medical School at Houston, Houston, TX, ⁷Rheumatology, University of Texas Medical School, Houston, TX, ⁸The University of Texas Health Science Center at Houston, Houston, TX, ⁹Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA
Background/Purpose: TNF-α inhibitor therapy is recommended by ASAS/EULAR guidelines for ankylosing spondylitis (AS) patients with moderate-to-high disease activity despite inadequate response to NSAIDs in addition…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].